ReviewOncology reports2024

The pathogenic response of cytotoxic T‑lymphocytes, a common therapeutic target for cancer, has a direct impact on treatment outcomes (Review).

Jing Luan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.